Skip to main content
. 2014 Aug 7;29(5):481–488. doi: 10.1097/HCO.0000000000000096

FIGURE 3.

FIGURE 3

TACT – Kaplan–Meier estimates of the primary composite endpoint EDTA chelation therapy vs. placebo subgroup of patients with diabetes mellitus. The primary endpoint was a composite of death from any cause, reinfarction, stroke, coronary revascularization, or hospitalization for angina. Reproduced with permission [16▪▪]. CI, confidence interval; HR, hazard ratio.